Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG:1349)
2.760
-0.050 (-1.78%)
May 12, 2026, 4:08 PM HKT
4.55% (1Y)
| Market Cap | 7.66B +16.8% |
| Revenue (ttm) | 744.45M -11.7% |
| Net Income | -173.22M |
| EPS | -0.22 |
| Shares Out | 1.04B |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.03 (1.14%) |
| Ex-Dividend Date | Jul 10, 2025 |
| Volume | 1,611,000 |
| Average Volume | 1,308,550 |
| Open | 2.810 |
| Previous Close | 2.810 |
| Day's Range | 2.750 - 2.810 |
| 52-Week Range | 2.570 - 5.290 |
| Beta | 0.14 |
| RSI | 47.44 |
| Earnings Date | Apr 29, 2026 |